Abstract
Laminin-1, a heterotrimer of α1, β1, and γ1 chains specific to basement membrane, promotes cell adhesion and migration, proteinase secretion and metastases of tumour cells. Several active sites on the α1 chain have been found to promote B16–F10 melanoma lung colonisation and here we have determined whether additional tumour promoting sites exist on the β1 and γ1 chains. Recently, we have identified novel cell adhesive peptides derived from laminin β1 and γ1 chains by systematic screening of synthetic peptides. Nine β1 peptides and seven γ1 peptides active for cell adhesion were tested for their effects on experimental pulmonary metastases of B16–F10 mouse melanoma cells in vivo. The most active adhesive peptide derived from the γ1 chain globular domain, C-16 (KAFDITYVRLKF), significantly enhanced pulmonary metastases of B16–F10 cells, whereas no other peptides showed enhancement. C-16 also stimulated migration of B16–F10 cells in the Boyden chamber assay in vitro. Furthermore, C-16 significantly induced the production of MMP-9 from B16–F10 cells. These results suggest that this specific laminin γ1 chain peptide has a metastasis-promoting activity and might be a new molecular target of anti-cancer treatment.
Similar content being viewed by others
Main
Laminin-1 is part of a family of glycoproteins specific to basement membrane. It has multiple biological activities including promoting cell adhesion, migration, differentiation, neurite outgrowth and tumour cell malignancy (Timpl et al, 1979; Kleinman et al, 1985; Martin and Timpl, 1987; Timpl, 1989). Laminin-1 enhances the metastatic phenotype of tumour cells (Terranova et al, 1982, 1984; Barsky et al, 1984). In addition, laminin-1 induces production of collagenase IV (Turpeenniemi-Hujanen et al, 1986), urokinase-type plasminogen activator, and the 92-kDa matrix metalloproteinase (MMP-9) (Khan and Falcone, 1997) in vitro.
Several biologically active sites on mouse laminin-1 that affect tumour cells have been previously identified using synthetic peptides (Yamada and Kleinman, 1992). YIGSR on the β1 chain promotes tumour cell adhesion and migration (Graf et al, 1987a, 1987b; Iwamoto et al, 1988) and inhibits experimental pulmonary metastases of mouse melanoma cells and angiogenesis (Iwamoto et al, 1987; Sakamoto et al, 1991). IKVAV on the α1 chain promotes cell adhesion, tumour growth, angiogenesis, collagenase IV activity by tumour cells, and experimental metastases as well as plasminogen activator activation (Grant et al, 1989; Tashiro et al, 1989; Kanemoto et al, 1990; Stack et al, 1991; Nomizu et al, 1992).
Recently, we have systematically screened a large set of overlapping synthetic peptides covering the whole mouse laminin-1 for their cell adhesive activities. Five peptides from the G-domain of α1 chain (Nomizu et al, 1995), 12 peptides from the γ1 chain (Nomizu et al, 1997), 21 peptides from the short and long arms of α1 chain (Nomizu et al, 1998), and 12 peptides from the β1 chain (Nomizu et al, 2000) were found to have significant cell adhesive activity. In addition, several peptides from the laminin-1 have been identified to be active for angiogenesis (Malinda et al, 1999; Ponce et al, 1999), acinar formation of salivary gland (Hoffman et al, 1998), and neurite outgrowth (Powell et al, 2000).
We previously identified several laminin α1 peptides that influence the metastatic activities of B16–F10 melanoma cells. AG-73 peptide from the α1 G-domain causes liver metastases (Kim et al, 1998), A-13 peptide from the N-terminal globule promotes an increase in pulmonary metastases (Kuratomi et al, 1999), and the AG-73 peptide (LQVQLSIR) promotes increased lung colonies and liver metastases. Here we report effects of adhesive peptides from the β1 and γ1 chains on experimental pulmonary metastases of B16–F10 cells in vivo. We have screened other adhesive peptides from β1 and γ1 chains for metastatic activity. We found that one of the peptides derived from the short arm of γ1 chain, C-16 (KAFDITYVRLKF), significantly enhanced pulmonary metastases of B16–F10 cells. This peptide also stimulated the migration of B16–F10 cells in the Boyden chamber assay. In addition, C-16 significantly induced production of MMP-9 by B16–F10 cells.
Materials and methods
Preparation of synthetic peptides
Cell adhesive peptides from the laminin β1 and γ1 chain and control peptides were synthesised and purified by high performance liquid chromatography as previously described (Nomizu et al, 1997). The purity and identity of the peptides were confirmed by an analytical HPLC and a Sciex API IIIE triple quadruple ion spray mass spectrometer.
Cells and culture
B16–F10 mouse melanoma cells (Fidler and Nicolson, 1976) (a gift of Dr IJ Fidler, Houston, TX, USA) were maintained in Dulbecco's modified Eagle's medium (DMEM; Life Technologies, Inc.) containing 10% foetal bovine serum (FBS; Hyclone, UT, USA), 100 units ml−1 penicillin, 100 μg ml−1 streptomycin (Life Technologies, Inc.).
In vivo experimental pulmonary metastasis assay
For the in vivo experimental pulmonary metastasis assay, B16–F10 cells were detached by 0.02% EDTA in phosphate buffered saline (Versene, Life Technologies, Inc.) and suspended in DMEM (1 000 000 cells ml−1). The cell suspension (0.2 ml) was injected into the tail veins of female C57BL6/N mice (9–12 weeks old). 0.2 mg of cell adhesion peptides (1 mg ml−1 in DMEM) was also intravenously injected within 10 min after the cell injection to exclude cell aggregations by mixture of peptide and cells. The mice were sacrificed 16 days after injection. The lungs were removed, and the number of visible colonies on the surface of the lungs was counted. When many colonies were formed and the number of the colonies could not be counted correctly because of the fusion of the colonies, the number was scored as 500. Five mice were used for each peptide. Duplicate experiments gave similar results.
All animals were maintained in filter top micro isolator cages and provided with sterile water and food under conditions complying with National Institute of Health (NIH) regulations. All manipulations of experimental animals were conducted in a laminar flow hood using strictly controlled procedures adhering to the UKCCCR Guidelines for the Welfare of Animals in Experimental Neoplasia to minimise stress or suffering (UKCCCR, 1998).
In vitro migration assay
Migration of B16–F10 cells through polycarbonate filters was assayed using 48 well chemotaxis chambers (modified Boyden chamber, Neuro Probe, MD, USA) as described previously (Kuratomi et al, 1999). The lower wells of the chamber were loaded with DMEM containing 0.1% bovine serum albumin (BSA, Sigma) (DMEM/BSA) and 100 μg ml−1 of peptide. Versene-detached B16–F10 cells (50 000 cells per 50 μl in DMEM/BSA) were placed in the upper wells. After a 5 h incubation, cells on the lower surface of the filter were stained with Diff-Quik (Baxter, IL, USA), and counted under a microscope. Each peptide was tested in triplicate and each experiment was repeated at least twice.
Zymography
B16–F10 cells (2 500 000 cells) were plated onto 150 mm dishes with complete media. After 24 h, the media were replaced with serum-free DMEM containing various concentrations of peptides. The conditioned media were collected after a 16 h incubation at 37°C in 5% CO2 and concentrated 50 times by using Centriprep 10 (Amicon). Equal aliquots of the conditioned media (20 μl per lane) were electrophoresed on 10% polyacrylamide gels containing 0.2% gelatin. The gels were washed with 10 mM Tris-HCl (pH 7.4) containing 2.5% Triton-X for 30 min, followed by two changes of 10 mM Tris-HCl (pH 7.4) for 30 min. After an overnight incubation in 50 mM Tris-HCl (pH 8.0) containing 5 mM CaCl2 and 1 mM ZnCl2 at room temperature, Coomassie blue was added to visualise the digested gelatin bands.
Results
Effect of cell adhesive laminin β1 and γ1 chain peptides on experimental pulmonary metastasis of B16–F10 mouse melanoma cells
Nine peptides active for cell adhesion from the mouse laminin β1 chain (Nomizu et al, 2000) and seven peptides from the γ1 chain (Nomizu et al, 1997) were tested for their effects on in vivo experimental pulmonary metastases of B16–F10 mouse melanoma cells (Table 1). In control experiments (without peptides), the average of 163 metastatic colonies was formed on the surface of the lung within 16 days after B16–F10 cells were injected into the mouse tail vein (Table 2). Peptide C-16 (KAFDITYVRLKF) from the N-terminal globular domain of the γ1 chain significantly enhanced the number of B16–F10 lung colonies (average of 482 colonies, Table 2 and Figure 1). No other peptides showed stimulation or inhibition of pulmonary metastases of B16–F10 cells (data not shown). A scrambled peptide of C-16, C-16T (FYAFKKITLVRD), slightly increased the number of B16–F10 lung colonies (average of 234 colonies with range from 90 to 345), but the difference was not significant (Table 2, Figure 1). These results suggested a sequence-specific enhancement of in vivo pulmonary metastases of B16–F10 cells by C-16.
In vitro cell migration
In order to study the mechanism of the enhancement of B16–F10 lung colonisation by C-16, we examined the activities of these 16 cell adhesive peptides for cell migration. Among the 16 cell adhesive peptides, 8 peptides (B-32, 34, 62, 133, 160; C-16, 64, 68) stimulated migration of B16–F10 cells, with C-16 having the strongest enhancement activity (Figure 2). The migration–stimulatory activity of C-16 seemed to be comparable to that of peptide A-13 from the α1 chain which previously was shown to be highly active (Nomizu et al, 1998; Kuratomi et al, 1999). A control scrambled peptide, C-16T, showed no stimulatory activity of B16–F10 cell migration.
Gelatin zymography
Because matrix metalloproteinases (MMPs) have been implicated in the metastatic process of tumour cells, we measured MMP production from B16–F10 cells in the gelatin zymography assays (Figure 3). C-16 enhanced the production of MMP-9 (92 kDa gelatinase) in a dose-dependent manner. With 20 μg ml−1 of C-16, MMP-9 production was increased by approximately eight-fold over that observed with the untreated control. MMP-2 production was not stimulated by C-16. No other cell adhesive peptides from the β1 and γ1 chains stimulated the production of MMPs (data not shown).
Discussion
Laminin-1 has been shown to promote the metastatic activity of melanoma cells (Terranova et al, 1982, 1984). We previously reported that several peptide sequences including RQVFQVAYIIIKA (A-13), IKVAV, and LQVQLSIR (AG-73) from the laminin α1 chain have such activity (Kanemoto et al, 1990; Kim et al, 1998; Kuratomi et al, 1999). In this report, we identified a new site, C-16 (KAFDITYVRLKF), on the laminin γ1 chain which promotes lung colonisation of B16–F10 cells in an experimental pulmonary metastasis model in mice.
C-16 enhanced B16–F10 colonization about three-fold compared with control. C-16 appears to be the only site on the γ1 chain of laminin-1 active for lung colonisation and no site on the β1 chain was found to have this activity. C-16-mediated metastasis promoting activity is comparable to that of A-13 and IKVAV. Since laminin-1 is a highly potent promoter of the malignant phenotype, it is not surprising that multiple sites for metastases have been identified.
The mechanism by which A-13 and C-16 increase lung colonisation is not known. Cells must adhere, migrate, invade (protease activity), proliferate, and generate blood supply in order to form a growing metastatic lesion. A-13 and C-16 have been found to promote all of these activities except cell proliferation. The role of A-13 and C-16 in angiogenesis in the metastatic lesion has not been tested. We did not examine the vascularity of the lung lesions and it is unlikely that A-13 and C-16 persists in the circulation or tissue for very long after injection. These are small molecules which are cleared very rapidly from the circulation. We speculate that A-13 and C-16 may enhance lung metastases by increasing the invasion activity of the cells.
Laminin-1 stimulates cell migration (Kleinman et al, 1985) and laminin α1 peptides with metastasis-promoting activity also have activity for the migration of B16–F10 cells (Kuratomi et al, 1999). We have shown here that five β1 peptides and three γ1 peptides stimulated migration of B16–F10 cells, with C-16 being most active and comparable to A-13. Thus, laminin-1 has multiple active sites for cell migration, which may function cooperatively.
Matrix metalloproteinases have been thought to be critical in tumour invasion and metastases as well as in angiogenesis (Liotta, 1986; Liotta et al, 1991; Kohn and Liotta, 1995). C-16 showed strong stimulation of MMP-9 production by B16–F10 cells. The IKVAV peptide from the laminin α1 chain also induces MMP-1 and MMP-9 production from human monocyte/macrophage (Corcoran et al, 1995). AG-73 was also reported to stimulate MMP-9 activity of B16–F10 cells at the concentration of 50 μg ml−1 (Kim et al, 1998). C-16 is more potent in inducing MMP-9 production than AG-73. C-16 stimulated MMP-9 production nearly eight-fold at a concentration of 2 μg ml−1. This high activity of C-16 for MMP-9 production as well as for cell migration may explain its potent metastasis-promoting activity.
Recently, expression of the γ2 chain of laminin-5, an epithelial cell–specific laminin, was predominantly detected at the invasive front of cancer cells of the colon, pancreas, stomach and oesophagus (Pyke et al, 1995; Soini et al, 1996; Sordat et al, 1998; Koshikawa et al, 1999; Yamamoto et al, 2001). The laminin γ2 chain has been suggested to play a key role in the progression of human carcinomas. C-16 is located in the N-terminal globular domain of the laminin γ1 chain, and this domain is deleted in the γ2 chain. However, it is possible that the deleted N-terminal globular domain is co-expressed with laminin γ2 chain by the proteolytic cleavage of the γ2 chain and that the cleaved domain induces migration and metastases of tumour cells in human cancers. Indeed, Giannelli et al (1997) have reported that laminin-5 becomes active for promoting cell migration when cleaved by MMP-2. It is possible that these active fragments of laminin-1 promote cell migration when it is degraded similar to laminin-5.
Four novel active sites (IKVAV, AG-73, A-13 and C-16) on mouse laminin-1 have been identified for B16–F10 cell adhesion, migration, MMP secretion, and metastases in this report and in previous studies (Figure 4) (Kanemoto et al, 1990; Kim et al, 1998; Kuratomi et al, 1999). Interestingly, A-13 and C-16 are in homologous locations on their respective chains at the amino termini, binding to the same receptors and have similar activity (Ponce et al, 2001; and unpublished data). Of the 12 amino acids, three amino acids are identical and five are conserved. Preservation of sequences and activity suggest important functional sites. Degradation of laminin chains may also be important in exposure of these active sites. These active sites might be new molecular targets of anti-cancer treatments which prevent distant metastases of malignant tumours. Furthermore, specific antibodies to these sites and inhibitory peptides might lead to development of therapeutic agents for human malignant tumours.
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Barsky SH, Rao CN, Williams JE, Liotta LA (1984) Laminin molecular domains which alter metastasis in a murine model. J Clin Invest 74: 843–848
Corcoran ML, Kibbey MC, Kleinman HK, Wahl LM (1995) Laminin SIKVAV peptide induction of monocyte/macrophage prostaglandin E2 and matrix metalloproteinases. J Biol Chem 270: 10365–10368
Fidler IJ, Nicolson GL (1976) Organ selectivity for implantation survival and growth of B16 melanoma variant tumor lines. J Natl Cancer Inst 57: 1199–1202
Giannelli G, Falk-Marzillier J, Schiraldi O, Stetler-Stevenson WG, Quaranta V (1997) Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science 277: 225–228
Graf J, Iwamoto Y, Sasaki M, Martin GR, Kleinman HK, Robey FA, Yamada Y (1987a) Identification of an amino acid sequence in laminin mediating cell attachment, chemotaxis, and receptor binding. Cell 48: 989–996
Graf J, Ogle RC, Robey FA, Sasaki M, Martin GR, Yamada Y, Kleinman HK (1987b) A pentapeptide from the laminin B1 chain mediates cell adhesion and binds the 67,000 laminin receptor. Biochemistry 26: 6896–6900
Grant DS, Tashiro K-I, Segui-Real B, Yamada Y, Martin GR, Kleinman HK (1989) Two different laminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vitro. Cell 58: 933–943
Hoffman MP, Nomizu M, Roque E, Lee S, Jung DW, Yamada Y, Kleinman HK (1998) Laminin-1 and laminin-2 G-domain synthetic peptides bind syndecan-1 and are involved in acinar formation of a human submandibular gland cell line. J Biol Chem 273: 28633–28641
Iwamoto Y, Robey FA, Graf J, Sasaki M, Kleinman HK, Yamada Y, Martin GR (1987) YIGSR, a synthetic laminin pentapeptide, inhibits experimental metastasis formation. Science 238: 1132–1134
Iwamoto Y, Graf J, Sasaki M, Kleinman HK, Greatorex DR, Martin GR, Robey FA, Yamada Y (1988) Synthetic pentapeptide from the B1 chain of laminin promotes B16F10 melanoma cell migration. J Cell Physiol 134: 287–291
Kanemoto T, Reich R, Royce L, Greatorex D, Adler SH, Shiraishi N, Martin GR, Yamada Y, Kleinman HK (1990) Identification of an amino acid sequence from the laminin A chain that stimulates metastasis and collagenase IV production. Proc Natl Acad Sci 87: 2279–2283
Khan KMF, Falcone DJ (1997) Role of laminin in matrix induction of macrophage urokinase-type plasminogen activator and 92-kDa metalloproteinase expression. J Biol Chem 272: 8270–8275
Kim WH, Nomizu M, Song S-Y, Tanaka K, Kuratomi Y, Kleinman HK, Yamada Y (1998) Laminin α1 chain sequence Leu-Gln-Val-Gln-Leu-Ser-Ile-Arg (LQVQLSIR) enhances murine melanoma cell metastasis. Int J Cancer 77: 632–639
Kleinman HK, Cannon FB, Laurie GW, Hassell JR, Aumailley M, Terranova VP, Martin GR, DuBois-Dalcq M (1985) Biological activities of laminin. J Cell Biochem 27: 317–325
Kohn EC, Liotta LA (1995) Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res 55: 1856–1862
Koshikawa N, Moriyama K, Takamura H, Mizushima H, Nagashima Y, Yanoma S, Miyazaki K (1999) Overexpression of laminin γ2 chain monomer in invading gastric carcinoma cells. Cancer Res 59: 5596–5601
Kuratomi Y, Nomizu M, Nielsen PK, Tanaka K, Song S-Y, Kleinman KH, Yamada Y (1999) Identification of metastasis-promoting sequences in the mouse laminin α1 chain. Exp Cell Res 249: 386–395
Liotta LA (1986) Tumor invasion and metastases role of the extracellular matrix: Rhoads Memorial Award lecture. Cancer Res 46: 1–7
Liotta LA, Steeg PS, Stetler-Stevenson WG (1991) Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64: 327–336
Malinda KM, Nomizu M, Chung M, Delgado M, Kuratomi Y, Yamada Y, Kleinman HK, Ponce ML (1999) Identification of laminin α1 and β1 chain peptides active for endothelial cell adhesion, tube formation and aortic sprouting. FASEB J 13: 53–62
Martin GR, Timpl R (1987) Laminin and other basement membrane components. Annu Rev Cell Biol 3: 57–85
Nomizu M, Utani A, Shiraishi N, Kibbey MC, Yamada Y, Roller PP (1992) The all-D-configuration segment containing the IKVAV sequence of laminin A chain has similar activities to the all-L-peptide in vitro and in vivo. J Biol Chem 267: 14118–14121
Nomizu M, Kim WH, Yamamura K, Utani A, Song S-Y, Otaka A, Roller PP, Kleinman HK, Yamada Y (1995) Identification of cell binding sites in the laminin α1 chain carboxyl-terminal globular domain by systematic screening of synthetic peptides. J Biol Chem 270: 20583–20590
Nomizu M, Kuratomi Y, Song S-Y, Ponce ML, Hoffman MP, Powell SK, Miyoshi K, Otaka A, Kleinman HK, Yamada Y (1997) Identification of cell binding sequences in mouse laminin γ1 chain by systematic peptide screening. J Biol Chem 272: 32198–32205
Nomizu M, Kuratomi Y, Malinda KM, Song S-Y, Miyoshi K, Otaka A, Powell SK, Hoffman MP, Kleinman HK, Yamada Y (1998) Cell binding sequences in laminin α1 chain. J Biol Chem 273: 32491–32499
Nomizu M, Kuratomi Y, Ponce ML, Song S-Y, Miyoshi K, Otaka A, Powell SK, Hoffman MP, Kleinman HK, Yamada Y (2000) Cell adhesive sequences in mouse laminin β1 chain. Arch Biochem Biophys 378: 311–320
Ponce ML, Nomizu M, Delgado MC, Kuratomi Y, Hoffman MP, Powell SK, Yamada Y, Kleinman HK, Malinda KM (1999) Identification of endothelial cell type specific sites on laminin γ1 chain. Circ Res 84: 688–694
Ponce ML, Nomizu M, Kleinman HK (2001) An angiogenic laminin site and its antagonist bind through the αvβ3 and α5β1 integrins. FASEB J 15: 1389–1397
Powell SK, Rao J, Roque E, Nomizu M, Kuratomi Y, Yamada Y, Kleinman HK (2000) Neural cell response to multiple novel sites on laminin-1. J Neurosci Res 61: 302–312
Pyke C, Salo S, Ralfkiaer E, Romer J, Dano K, Tryggvason K (1995) Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas. Cancer Res 55: 4132–4139
Sakamoto N, Iwahana M, Tanaka NG, Osada Y (1991) Inhibition of angiogenesis and tumor growth by a synthetic laminin peptide, CDPGYIGSR-NH2. Cancer Res 51: 903–906
Soini Y, Maatta M, Salo S, Tryggvason K, Autio-Harmainen H (1996) Expression of the laminin γ2 chain in pancreatic adenocarcinoma. J Pathol 180: 290–294
Sordat I, Bosman FT, Dorta G, Rousselle P, Aberdam D, Blum AL, Sordat B (1998) Differential expression of laminin-5 subunits and integrin receptors in human colorectal neoplasia. J Pathol 185: 44–52
Stack S, Gray RD, Pizzo SV (1991) Modulation of plasminogen activation and type IV collagenase activity by a synthetic peptide derived from the laminin A chain. Biochemistry 30: 2073–2077
Tashiro K, Sephel GC, Weeks B, Sasaki M, Martin GR, Kleinman HK, Yamada Y (1989) A synthetic peptide containing the IKVAV sequence from the A chain of laminin mediates cell attachment, migration, and neurite outgrowth. J Biol Chem 264: 16174–16182
Terranova VP, Liotta LA, Russo RG, Martin GR (1982) Role of laminin in the attachment and metastasis of murine tumor cells. Cancer Res 46: 2265–2269
Terranova VP, Williams JE, Liotta LA, Martin GR (1984) Modulation of the metastatic activity of melanoma cells by laminin and fibronectin. Science 226: 982–985
Timpl R, Rohde H, Robey PG, Rennard SI, Foidart JM, Martin GR (1979) Laminin – a glycoprotein from basement membranes. J Biol Chem 254: 9933–9937
Timpl R (1989) Structure and biological activity of basement membrane proteins. Eur J Biochem 180: 148–502
Turpeenniemi-Hujanen T, Thorgeirsson UP, Rao CN, Liotta LA (1986) Laminin increases the release of type IV collagenase from malignant cells. J Biol Chem 261: 1883–1889
UKCCCR (1998) United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the Welfare of Animals in Experimental Neoplasia 2nd edn. Br J Cancer 77: 1–10
Yamada Y, Kleinman HK (1992) Functional domains of cell adhesion molecules. Curr Opin Cell Biol 4: 819–823
Yamamoto H, Itoh F, Iku S, Hosokawa M, Imai K (2001) Expression of the γ(2) chain of laminin-5 at the invasive front is associated with recurrence and poor prognosis in human esophageal squamous cell carcinoma. Clin Cancer Res 7: 896–900
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Kuratomi, Y., Nomizu, M., Tanaka, K. et al. Laminin γ1 chain peptide, C-16 (KAFDITYVRLKF), promotes migration, MMP-9 secretion, and pulmonary metastasis of B16–F10 mouse melanoma cells. Br J Cancer 86, 1169–1173 (2002). https://doi.org/10.1038/sj.bjc.6600187
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6600187
Keywords
This article is cited by
-
NUDT21 alters glioma migration through differential alternative polyadenylation of LAMC1
Journal of Neuro-Oncology (2023)
-
Dynamic light scattering: a practical guide and applications in biomedical sciences
Biophysical Reviews (2016)
-
Angiotropism, Pericytic Mimicry and Extravascular Migratory Metastasis in Melanoma: An Alternative to Intravascular Cancer Dissemination
Cancer Microenvironment (2014)
-
MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression
British Journal of Cancer (2013)
-
Association between laminin γ1 expression and meningioma grade, recurrence, and progression-free survival
Acta Neurochirurgica (2013)